249 related articles for article (PubMed ID: 26876567)
1. Tissue Metabonomic Phenotyping for Diagnosis and Prognosis of Human Colorectal Cancer.
Tian Y; Xu T; Huang J; Zhang L; Xu S; Xiong B; Wang Y; Tang H
Sci Rep; 2016 Feb; 6():20790. PubMed ID: 26876567
[TBL] [Abstract][Full Text] [Related]
2. Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC/MS).
Chan EC; Koh PK; Mal M; Cheah PY; Eu KW; Backshall A; Cavill R; Nicholson JK; Keun HC
J Proteome Res; 2009 Jan; 8(1):352-61. PubMed ID: 19063642
[TBL] [Abstract][Full Text] [Related]
3. 1H HR-MAS NMR spectroscopy of tumor-induced local metabolic "field-effects" enables colorectal cancer staging and prognostication.
Jiménez B; Mirnezami R; Kinross J; Cloarec O; Keun HC; Holmes E; Goldin RD; Ziprin P; Darzi A; Nicholson JK
J Proteome Res; 2013 Feb; 12(2):959-68. PubMed ID: 23240862
[TBL] [Abstract][Full Text] [Related]
4. UHPLC-HRMS-based Multiomics to Explore the Potential Mechanisms and Biomarkers for Colorectal Cancer.
Wang X; Guan X; Tong Y; Liang Y; Huang Z; Wen M; Luo J; Chen H; Yang S; She Z; Wei Z; Zhou Y; Qi Y; Zhu P; Nong Y; Zhang Q
BMC Cancer; 2024 May; 24(1):644. PubMed ID: 38802800
[TBL] [Abstract][Full Text] [Related]
5. Metabotyping of human colorectal cancer using two-dimensional gas chromatography mass spectrometry.
Mal M; Koh PK; Cheah PY; Chan EC
Anal Bioanal Chem; 2012 Apr; 403(2):483-93. PubMed ID: 22374317
[TBL] [Abstract][Full Text] [Related]
6. Urinary metabonomic study on colorectal cancer.
Qiu Y; Cai G; Su M; Chen T; Liu Y; Xu Y; Ni Y; Zhao A; Cai S; Xu LX; Jia W
J Proteome Res; 2010 Mar; 9(3):1627-34. PubMed ID: 20121166
[TBL] [Abstract][Full Text] [Related]
7. Staging research of human lung cancer tissues by high-resolution magic angle spinning proton nuclear magnetic resonance spectroscopy (HRMAS
Chen W; Lu S; Wang G; Chen F; Bai C
Asia Pac J Clin Oncol; 2017 Oct; 13(5):e232-e238. PubMed ID: 27670847
[TBL] [Abstract][Full Text] [Related]
8. Interspecies Developmental Differences in Metabonomic Phenotypes of Lycium ruthenicum and L. barbarum Fruits.
Wang Q; Zeng S; Wu X; Lei H; Wang Y; Tang H
J Proteome Res; 2018 Sep; 17(9):3223-3236. PubMed ID: 30085679
[TBL] [Abstract][Full Text] [Related]
9. Distinct urinary metabolic profile of human colorectal cancer.
Cheng Y; Xie G; Chen T; Qiu Y; Zou X; Zheng M; Tan B; Feng B; Dong T; He P; Zhao L; Zhao A; Xu LX; Zhang Y; Jia W
J Proteome Res; 2012 Feb; 11(2):1354-63. PubMed ID: 22148915
[TBL] [Abstract][Full Text] [Related]
10. Interplay between post-translational cyclooxygenase-2 modifications and the metabolic and proteomic profile in a colorectal cancer cohort.
Prieto P; Jaén RI; Calle D; Gómez-Serrano M; Núñez E; Fernández-Velasco M; Martín-Sanz P; Alonso S; Vázquez J; Cerdán S; Peinado MÁ; Boscá L
World J Gastroenterol; 2019 Jan; 25(4):433-446. PubMed ID: 30700940
[TBL] [Abstract][Full Text] [Related]
11.
Lin Y; Ma C; Bezabeh T; Wang Z; Liang J; Huang Y; Zhao J; Liu X; Ye W; Tang W; Ouyang T; Wu R
Int J Cancer; 2019 Sep; 145(6):1679-1689. PubMed ID: 30720869
[TBL] [Abstract][Full Text] [Related]
12. [Proton nuclear magnetic resonance spectroscopy recognition of metabolic patterns in fecal extracts for early diagnosis of colorectal cancer].
Lin Y; Wang ZN; Ma CC; Liu CK; Yang JR; Shen ZW; Wu RH
Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Sep; 50(9):788-793. PubMed ID: 27655598
[No Abstract] [Full Text] [Related]
13. Lipidomic Signatures for Colorectal Cancer Diagnosis and Progression Using UPLC-QTOF-ESI
Răchieriu C; Eniu DT; Moiş E; Graur F; Socaciu C; Socaciu MA; Hajjar NA
Biomolecules; 2021 Mar; 11(3):. PubMed ID: 33799830
[TBL] [Abstract][Full Text] [Related]
14. A validated metabolomic signature for colorectal cancer: exploration of the clinical value of metabolomics.
Farshidfar F; Weljie AM; Kopciuk KA; Hilsden R; McGregor SE; Buie WD; MacLean A; Vogel HJ; Bathe OF
Br J Cancer; 2016 Sep; 115(7):848-57. PubMed ID: 27560555
[TBL] [Abstract][Full Text] [Related]
15. Specificity of metabolic colorectal cancer biomarkers in serum through effect size.
Di Giovanni N; Meuwis MA; Louis E; Focant JF
Metabolomics; 2020 Aug; 16(8):88. PubMed ID: 32789702
[TBL] [Abstract][Full Text] [Related]
16. Global metabolite profiling of human colorectal cancer xenografts in mice using HPLC-MS/MS.
Loftus NJ; Lai L; Wilkinson RW; Odedra R; Wilson ID; Barnes AJ
J Proteome Res; 2013 Jun; 12(6):2980-6. PubMed ID: 23631600
[TBL] [Abstract][Full Text] [Related]
17. Metabonomic characteristics and biomarker research of human lung cancer tissues by HR1H NMR spectroscopy.
Chen W; Lu S; Ou J; Wang G; Zu Y; Chen F; Bai C
Cancer Biomark; 2016 Mar; 16(4):653-64. PubMed ID: 27002768
[TBL] [Abstract][Full Text] [Related]
18. Study on metabonomic characteristics of human lung cancer using high resolution magic-angle spinning 1H NMR spectroscopy and multivariate data analysis.
Chen W; Zu Y; Huang Q; Chen F; Wang G; Lan W; Bai C; Lu S; Yue Y; Deng F
Magn Reson Med; 2011 Dec; 66(6):1531-40. PubMed ID: 21523825
[TBL] [Abstract][Full Text] [Related]
19. [Study on specific metabonomic profiling of serum from colorectal cancer patients by gas chromatography-mass spectrometry].
Ma YL; Liu WJ; Peng JY; Zhang P; Chen HQ; Qin HL
Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Jul; 12(4):386-90. PubMed ID: 19598026
[TBL] [Abstract][Full Text] [Related]
20. Hyper-Elongation in Colorectal Cancer Tissue - Cerotic Acid is a Potential Novel Serum Metabolic Marker of Colorectal Malignancies.
Mika A; Kobiela J; Czumaj A; Chmielewski M; Stepnowski P; Sledzinski T
Cell Physiol Biochem; 2017; 41(2):722-730. PubMed ID: 28214830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
